Fitzgerald Trae 4
4 · VIEMED HEALTHCARE, INC. · Filed Feb 2, 2026
Research Summary
AI-generated summary of this filing
Viemed Healthcare (VMD) CFO Trae Fitzgerald Receives and Sells Shares
What Happened
Trae Fitzgerald, Chief Financial Officer of Viemed Healthcare (VMD), reported vesting and settlement of equity awards on January 29, 2026. The filing shows conversion/exercise of derivative awards (RSUs and phantom share units) leading to the acquisition of 9,794 and 3,265 underlying shares, followed by company actions to satisfy tax and cash-settlement requirements: 2,679 shares were withheld to cover taxes (disposed at $7.48/share for $20,039) and 3,265 shares were disposed to the issuer at $7.48/share for $24,422. The filing also records derivative settlements reported at $0 value reflecting cash settlement of phantom shares.
Key Details
- Transaction date: January 29, 2026. Form filed: February 2, 2026 (appears timely).
- Reported transactions:
- Conversion/exercise of derivatives (M): 9,794 shares acquired (reported as derivative settlement).
- Conversion/exercise of derivatives (M): 3,265 shares acquired.
- Tax withholding (F): 2,679 shares withheld/disposed at $7.48 each = $20,039.
- Disposition to issuer (D): 3,265 shares sold to company at $7.48 each = $24,422.
- Derivative dispositions (M) for 9,794 and 3,265 shares reported at $0 reflecting cash settlement.
- Footnotes of note:
- F1/F5: RSUs represent rights to one common share; the RSUs were originally granted Jan 29, 2024 and vest in three annual installments.
- F4/F6: Phantom share units are cash-settled equivalents of common shares; settlement was cash-based and reported as simultaneous acquisition of underlying shares and disposition to the company.
- F2: Shares were withheld by the issuer to satisfy the reporting person’s tax obligation.
- Shares owned after the transactions are not specified in this Form 4.
Context: This appears to be routine vesting/settlement of RSUs and phantom share units with tax withholding and cash settlement to the company rather than an open-market sale or purchase. Such filings typically reflect compensation realization and tax-related withholding and do not, by themselves, indicate the insider’s market view.
Insider Transaction Report
- Exercise/Conversion
Common Shares
[F1]2026-01-29+9,794→ 108,317 total - Tax Payment
Common Shares
[F2][F3]2026-01-29$7.48/sh−2,679$20,039→ 105,638 total - Exercise/Conversion
Common Shares
[F4]2026-01-29+3,265→ 108,903 total - Disposition to Issuer
Common Shares
[F3]2026-01-29$7.48/sh−3,265$24,422→ 105,638 total - Exercise/Conversion
Restricted Stock Units
[F1][F5]2026-01-29−9,794→ 9,794 totalExp: 2027-01-29→ Common Shares (9,794 underlying) - Exercise/Conversion
Phantom Share Units
[F4][F6]2026-01-29−3,265→ 3,264 totalExp: 2027-01-29→ Common Shares (3,265 underlying)
Footnotes (6)
- [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
- [F2]Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
- [F3]Per share value is based on the market closing price of the common shares for January 29, 2026.
- [F4]Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
- [F5]Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.
- [F6]Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.